AMN Healthcare Services (AMN)$27.66
Market Cap: 759.43 MCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for AMN Healthcare Services (AMN).
HEALTHCARE
MEDICAL CARE FACILITIES
DCF ready
Valuation
6.4x
EV/FCF, 15.7% FCF yield
Quality
-6.8%
ROIC, 8.6% FCF margin
Growth
2.7%
5Y sales (revenue) CAGR
Balance sheet
1.2x
Debt/equity, 0.9x current ratio
Superinvestors
1
Top: Tweedy Browne Co. (0.0%)
Strengths to research
- 10 annual periods are available for trend analysis.
Watchouts
- Current ratio is below 1 at 0.9x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for AMN.
Grade C
47
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| AMN Target | AMN Healthcare Services | $759.4M | -11.2x | 6.4x | -6.8% | 2.7% | 8.6% | 28.3% | 7.2x | N/A |
| EMBC | Embecta Corp | $724.4M | 2.0x | 10.4x | 12.8% | -0.1% | 16.9% | 62.6% | 4.1x | N/A |
| NUVB | Nuvation Bio Inc. | $808.4M | -7.9x | -4.0x | -58.0% | N/A | -275.7% | N/A | N/A | N/A |
| RCKT | Rocket Pharmaceuticals Inc. | $838.3M | -1.5x | -4.0x | -80.5% | N/A | N/A | N/A | N/A | N/A |
| CDNA | CareDx Inc. | $843.4M | -54.1x | 18.5x | -7.0% | 14.6% | 11.1% | N/A | N/A | N/A |
| TRVI | Trevi Therapeutics Inc. | $667.1M | -44.2x | -15.4x | -23.3% | N/A | N/A | N/A | N/A | N/A |
| INMD | InMode Ltd. | $868.1M | 9.6x | 6.7x | 13.7% | 12.4% | 22.7% | 78.5% | -3.5x | N/A |
| AORT | Artivion Inc. | $1.0B | 107.0x | 1388.5x | 1.5% | 11.8% | 0.2% | 64.4% | 2.7x | N/A |
| PHVS | Pharvaris NV | $1.0B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Financial Charts
No financial data available for AMN (annual).
1 superinvestors own AMN
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Tweedy Browne Co. Tweedy Browne Value Fund | 27,963 | $513,000 | 0.04% | 0.0% |